Cipla sweetens on modest growth in quarterly earnings
Cipla surged 4.57% to Rs 180.75 at 10:21 IST on BSE, after the company posted a 6.07% rise in net profit to Rs 223.44 crore in Q3 December 2008 over Q3 December 2007.

Meanwhile, the BSE Sensex was down 23.22 points, or 0.26%, to 8,790.62.
On BSE, 92,560 shares were traded in the counter. The stock had an average daily volume of 2.20 lakh shares in the past one quarter.
The stock hit a high of Rs 181.80 and a low of Rs 175 during the day. The stock hit a 52-week high of Rs 243.55 on 28 August 2008 and a 52-week low of Rs 146.40 on 24 October 2008.
The large-cap stock had outperformed the market over the past one month till 22 January 2009, falling 6.52% as compared to the Sensex's decline of 13.08%. It had also outperformed the market in the past one quarter, falling 5.78% as compared to the Sensex's decline of 17.82%.
The company's current equity is Rs 155.45 crore. Face value per share is Rs 2.
The current price of Rs 180.75 discounts the company's Q3 December 2008 annualized EPS of Rs 11.50, by a PE multiple of 15.72.
Cipla's total income rose 22% to Rs 1360.48 crore in Q3 December 2008 over Q3 December 2007. The company unveiled the results after trading hours on Thursday, 22 January 2009.
The company has incurred a foreign exchange loss of Rs 42.63 crore for the quarter ended December 2008.
Cipla manufactures pharmaceutical products. The products of the company include anti-asthmatics, anti-cancer, anti-inflammatory, anti-depressant and other therapeutic index including animal health care products.
function winhelp(url)
{
mywin = window.open(url, 'mywin','height=270,width=360,scrollbars=yes,status=0,top=100,left=420, status=no,alwaysRaised=0,channelmode=0,fullscreen=0,hotkeys=1,menubar=0,resizable=1,titlebar=0,toolbar=0,z-lock=0');
if (mywin.focus)
mywin.focus()
}